|
Atomistry » Zinc » PDB 4c6p-4ci3 » 4cbt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Zinc » PDB 4c6p-4ci3 » 4cbt » |
Zinc in PDB 4cbt: Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons DiseaseEnzymatic activity of Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
All present enzymatic activity of Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease:
3.5.1.98; Protein crystallography data
The structure of Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease, PDB code: 4cbt
was solved by
R.W.Burli,
C.A.Luckhurst,
O.Aziz,
K.L.Matthews,
D.Yates,
K.A.Lyons,
M.Beconi,
G.Mcallister,
P.Breccia,
A.J.Stott,
S.D.Penrose,
M.Wall,
M.Lamers,
P.Leonard,
I.Mueller,
C.M.Richardson,
R.Jarvis,
L.Stones,
S.Hughes,
G.Wishart,
A.F.Haughan,
C.Oconnell,
T.Mead,
H.Mcneil,
J.Vann,
J.Mangette,
M.Maillard,
V.Beaumont,
I.Munoz-Sanjuan,
C.Dominguez,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4cbt:
The structure of Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
(pdb code 4cbt). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 6 binding sites of Zinc where determined in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease, PDB code: 4cbt: Jump to Zinc binding site number: 1; 2; 3; 4; 5; 6; Zinc binding site 1 out of 6 in 4cbtGo back to![]() ![]()
Zinc binding site 1 out
of 6 in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
![]() Mono view ![]() Stereo pair view
Zinc binding site 2 out of 6 in 4cbtGo back to![]() ![]()
Zinc binding site 2 out
of 6 in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
![]() Mono view ![]() Stereo pair view
Zinc binding site 3 out of 6 in 4cbtGo back to![]() ![]()
Zinc binding site 3 out
of 6 in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
![]() Mono view ![]() Stereo pair view
Zinc binding site 4 out of 6 in 4cbtGo back to![]() ![]()
Zinc binding site 4 out
of 6 in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
![]() Mono view ![]() Stereo pair view
Zinc binding site 5 out of 6 in 4cbtGo back to![]() ![]()
Zinc binding site 5 out
of 6 in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
![]() Mono view ![]() Stereo pair view
Zinc binding site 6 out of 6 in 4cbtGo back to![]() ![]()
Zinc binding site 6 out
of 6 in the Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Hdac Inhibitors As A Potential Therapy For Huntingtons Disease
![]() Mono view ![]() Stereo pair view
Reference:
R.W.Burli,
C.A.Luckhurst,
O.Aziz,
K.L.Matthews,
D.Yates,
K.A.Lyons,
M.Beconi,
G.Mcallister,
P.Breccia,
A.J.Stott,
S.D.Penrose,
M.Wall,
M.B.A.C.Lamers,
P.Leonard,
I.Mueller,
C.M.Richardson,
R.Jarvis,
L.Stones,
S.Hughes,
G.Wishart,
A.F.Haughan,
C.O'connell,
T.Mead,
H.Mcneil,
J.Vann,
J.Mangette,
M.Maillard,
V.Beaumont,
I.Munoz-Sanjuan,
C.Dominguez.
Design, Synthesis, and Biological Evaluation of Potent and Selective Class Iia Histone Deacetylase (Hdac) Inhibitors As A Potential Therapy For Huntington'S Disease. J.Med.Chem. V. 56 9934 2013.
Page generated: Sat Oct 26 20:45:33 2024
ISSN: ISSN 0022-2623 PubMed: 24261862 DOI: 10.1021/JM4011884 |
Last articlesZn in 9J0NZn in 9J0O Zn in 9J0P Zn in 9FJX Zn in 9EKB Zn in 9C0F Zn in 9CAH Zn in 9CH0 Zn in 9CH3 Zn in 9CH1 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |